/ Print /

Mari Edlin
Gene Therapy Advances: What Health Execs Should Know
Gene therapy is leaving its mark, while payers contemplate payment models, value, and efficacy issues.
PBMs Look to the Future
PBMs are evolving, but what will they be evolving into and will they be more transparent?